Dyslipidemia and reduced retinal layer thicknesses in mild to moderate non-proliferative diabetic retinopathy

被引:0
|
作者
Wu, Jingjing [1 ]
Chen, Yanrong [1 ]
Huang, Cuiting [1 ]
Wang, Yuqing [1 ]
Lin, Lingli [1 ]
Zhang, Zhaode [1 ]
机构
[1] Ningde Normal Univ, Dept Ophthalmol, Ningde Municipal Hosp, 13 Mindong East Rd, Ningde 352100, Fujian, Peoples R China
来源
关键词
Diabetic retinopathy; retinal nerve fiber layer; retinal ganglion cells; risk factors; OPTICAL COHERENCE TOMOGRAPHY; VASCULAR CHANGES; MACULAR EDEMA; SERUM-LIPIDS; NEURODEGENERATION; REPRODUCIBILITY; MELLITUS; PATHOGENESIS; DISEASE;
D O I
10.62347/EHTP6496
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the changes in ganglion cell layer-inner plexiform layer (GCL-IPL) thickness and its association with peripheral blood indices in non-proliferative diabetic retinopathy (NPDR). Methods: In this crosssectional study, 132 participants were categorized into three groups: 30 healthy volunteers (control group), 50 diabetic patients with non-diabetic retinopathy (NDR group), and 52 patients with NPDR. Optical coherence tomography (OCT) was used to measure the retinal nerve fiber layer (RNFL) and GCL-IPL thicknesses in the macula. The associations between RNFL loss and systemic risk factors for DR, such as diabetes duration, triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and hemoglobin A1c (HbA1c) were evaluated. Results: The average, superior, and nasal thicknesses in the NDR and NPDR groups were significantly thinner compared to the control group (P=0.002, 0.020, 0.090, respectively). Similarly, GCL-IPL thicknesses in the 3 mm and 6 mm zones of the NDR and NPDR groups were thinner than those in the control group (P=0.040, 0.022, 0.037, respectively). Temporal thicknesses in the 3 mm range of the NDR and NPDR groups were also thinner than in the control group (P=0.010). Superior RNFL thickness was positively correlated with HbA1c (r=0.200, P=0.044), and negatively correlated with HDL (r=-0.198, P=0.047). The average inferior and nasal GCL-IPL thicknesses were negatively correlated with TC across the 3 mm zone (r=-0.211, P=0.033; r=-0.224, P=0.023; r=-0.227, P=0.022). Additionally, the average thickness of GCL-IPL in the 6-mm range were positively correlated with the duration of diabetes (r=0.196, P=0.048). Conclusion: This study demonstrates that dyslipidemia in diabetic patients correlates with reductions in RNFL and GCL-IPL thicknesses, suggesting a role in the pathogenesis of diabetic retinopathy.
引用
收藏
页码:5718 / 5727
页数:10
相关论文
共 50 条
  • [21] Computer aided quantification for retinal lesions in patients with moderate and severe non-proliferative diabetic retinopathy: a retrospective cohort study
    Wu, Huiqun
    Zhang, Xiaofeng
    Geng, Xingyun
    Dong, Jiancheng
    Zhou, Guomin
    BMC OPHTHALMOLOGY, 2014, 14
  • [22] Effect of focal laser photocoagulation in eyes with early or moderate non-proliferative diabetic retinopathy
    Jeong, Seonghun
    Han, Jungil
    Lew, Young Ju
    Park, Saemi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [23] NUTRITIONAL AND ANTHROPOMETRIC PROFILE OF MILD NON-PROLIFERATIVE DIABETIC RETINOPATHY PATIENTS IN NORTHERN INDIA
    Kaur, Parmeet
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 490 - 490
  • [24] Nutritional and anthropometric profile of mild non-proliferative diabetic retinopathy patients in northern India
    Kaur, P.
    ANNALS OF NUTRITION AND METABOLISM, 2007, 51 : 363 - 363
  • [25] Two years evolution of alterations of the blood retinal barrier and retinal thickness in type 2 mild non-proliferative diabetic retinopathy.
    Lobo, CF
    Bernardes, RB
    de Abreu, JRF
    Cunha-Vaz, JG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S693 - S693
  • [26] One year evolution of alterations of the blood retinal barrier and retinal thickness in type 2 mild non-proliferative diabetic retinopathy.
    Cunha-Vaz, JG
    Lobo, C
    Bernardes, R
    de Abreu, JRF
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S951 - S951
  • [27] Treatment effects of captopril on non-proliferative diabetic retinopathy
    Wang Ning
    Zheng Zhi
    Jin Hui-yi
    Xu Xun
    CHINESE MEDICAL JOURNAL, 2012, 125 (02) : 287 - 292
  • [28] Targeting antioxidant strategies for non-proliferative diabetic retinopathy
    Campos-Borges, Cristina
    Pinazo-Duran, Maria D.
    Sanz-Gonzalez, Silvia Maria
    Garcia-Medina, Jose Javier
    Zanon-Moreno, Vicente
    Valero-Vello, Mar
    Salgado-Borges, Jose
    Duarte, Lilianne
    Lopez Galvez, Maria Isabel
    Prudencio, Cristina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [29] Subclinical Capillary Changes in Non-Proliferative Diabetic Retinopathy
    Tam, Johnny
    Dhamdhere, Kavita P.
    Tiruveedhula, Pavan
    Lujan, Brandon J.
    Johnson, Robert N.
    Bearse, Marcus A., Jr.
    Adams, Anthony J.
    Roorda, Austin
    OPTOMETRY AND VISION SCIENCE, 2012, 89 (05) : E692 - E703
  • [30] Predicting the development of local non-proliferative diabetic retinopathy
    Han, Y
    Schneck, ME
    Bearse, MA
    Barez, S
    Jacobsen, C
    Adams, AJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U362 - U362